Press Release: Advanced Cancer Therapeutics : Advanced Cancer Therapeutics' PFK-158 Selected as One of Informa and Kantar Health 2014 Top 10 Most Interesting Oncology Projects to Watch

Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, has been chosen by Informa and Kantar Health as one of the "2014 Top 10 Most Interesting Oncology Projects to Watch" for its compound, PFK-158. PFK-158 is a small molecule therapeutic candidate that inactivates a novel cancer metabolism target never before examined in human clinical trials. [PR.com]